Recent Advances in Understanding and Managing Alzheimer's Disease: from Pathogenesis to Treatment
Authors:
- Rafael Leituga de Carvalho CavalcanteRCRafael Leituga de Carvalho Cavalcante
- Maurício SamartinoMSMaurício Samartino
- Larissa Abussafi MirandaLMLarissa Abussafi Miranda
- Jeniffer da Silva Alencar MendesJMJeniffer da Silva Alencar Mendes
- Tatiana de Lima TanakaTTTatiana de Lima Tanaka
- Felipe de Oliveira SilvaFSFelipe de Oliveira Silva
- Lucas Monteiro MolinaLMLucas Monteiro Molina
- Bruno Carvalho DinizBDBruno Carvalho Diniz
- Daniela Alves DantasDDDaniela Alves Dantas
- Dhyana Ataide Ferraz SargesDSDhyana Ataide Ferraz Sarges
- Tiago Gonçalves de AraújoTATiago Gonçalves de Araújo
- Camila Almeida StoccoCSCamila Almeida Stocco
Open Access
- 2 January 2024
- journal article
- research article
- Published by RGSA- Revista de Gestao Social e Ambiental in Revista de Gestão Social e Ambiental
- Vol. 18 (1) , e07461
Abstract
Objective: The objective of this article is to conduct a comprehensive review of recent advances in understanding the pathogenesis of Alzheimer's disease (AD) and innovations in its management, emphasizing how these developments can inform more effective therapeutic strategies. Initially, this study explores contemporary findings related to the molecular and cellular mechanisms contributing to AD pathology, including the aggregation of beta-amyloid and tau, neural inflammation, synaptic dysfunction, as well as the impact of genetic and environmental factors. Theoretical Framework: Alzheimer's disease (AD) presents itself as a growing challenge for global public health, given its rising prevalence and the significant impact on the affected individuals, their families, and the healthcare systems. Method: A systematic review was conducted using major scientific databases to collect relevant articles on recent advances in the understanding and management of Alzheimer's disease, from pathogenesis to treatment. Specific keywords were used to identify studies addressing new findings and interdisciplinary therapeutic strategies. This enabled the synthesis of effective approaches and the identification of research gaps, supporting evidence-based clinical practices. Results and Discussion: Recent research has identified novel genetic markers linked to Alzheimer's disease, enhancing early diagnosis. Studies have also demonstrated the efficacy of integrated cognitive therapies in slowing disease progression. Additionally, new pharmacological treatments targeting amyloid plaques have shown promise in clinical trials. However, challenges in uniform treatment efficacy across diverse populations highlight the need for tailored therapeutic approaches.Keywords
This publication has 37 references indexed in Scilit:
- Alzheimer's disease2019
- Alzheimer’s disease (AD) therapeutics – 1: Repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causalityBiochemical Pharmacology, 2018
- CDT2‐controlled cell cycle reentry regulates the pathogenesis of Alzheimer's diseaseAlzheimer's & Dementia, 2018
- Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approachJournal of Proteomics, 2018
- NIA‐AA Research Framework: Toward a biological definition of Alzheimer's diseaseAlzheimer's & Dementia, 2018
- CSF biomarkers of Alzheimer's disease concord with amyloid‐β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohortsAlzheimer's & Dementia, 2018
- Anti-Amyloid-β Monoclonal Antibodies for Alzheimer’s Disease: Pitfalls and PromiseBiological Psychiatry, 2018
- Lipids in the nervous system: From biochemistry and molecular biology to patho-physiologyBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2015
- The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011
- Apolipoprotein E polymorphism and Alzheimer's diseaseThe Lancet, 1993